| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |